Celltrion stock

South Korean biopharmaceutical company Celltrion Inc. on Friday said it applied for approval from the US Food and Drug Administration (FDA) for CT-P...

South Korea’s National Pension Service (NPS) has logged an 8.63% profit in fund management in January-April this year thanks to strong equity ...

Shares of CJ CGV Co., South Korea’s top multiplex cinema chain, hit the lowest level since the 2008-09 global financial crisis on Wednesday as...

South Korea’s Celltrion Inc. has put its Japanese Takeda Pharmaceutical Co.'s primary care assets acquired in 2020 on sale as the biosimilar g...

South Korea's biopharmaceutical company Celltrion Inc. announced that it received on Thursday approval from the US Food and Drug Administration (FDA...

Goldman Sachs Group Inc. has slashed the target prices of South Korean top cathode stocks, namely EcoPro BM Co. and POSCO Future M Co., by nearly ha...

Foreigners bought a record $11.43 billion in South Korean stocks and bonds in May, boosting the value of the won versus the dollar amid the greenbac...

South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it plans to beef up its portfolio by applying for regulatory approv...

South Korea's biopharmaceutical company Celltrion Inc. announced on Monday that it has signed a contract with the US biotech firm Rani Therapeutics ...

MILAN – South Korea's biopharmaceutical company Celltrion Inc. is known in Europe for its biosimilar products such as autoimmune disease treat...

South Korean biosimilar giant Celltrion Inc. revealed on Wednesday the highly anticipated clinical phase 1 data for its Actemra biosimilar, CT-P47, ...

Three HYBE employees on Wednesday were accused of insider stock trading, allegedly selling the South Korean entertainment giant's shares before K-po...

More than 500 South Korean companies from top business groups to AI-based biotech startups are slated to attend the Bio International Convention 202...

South Korea’s main bourse Kospi on Tuesday hit its highest closing since June last year, boosted by foreigners’ net buying in semiconduc...

South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has obtained product approval from the US Food and Drug Adminis...

Foreigners reported a record purchase of South Korean shares despite a global economic slowdown, as money moved from the US and Europe into emerging...

South Korean biopharmaceutical company Celltrion Healthcare Co. revealed on Monday its introduction of Remsima SC, a treatment for autoimmune diseas...

Foreign investors' appetite for South Korean stocks remains insatiable, mainly for semiconductor heavyweights, underscoring their high expectations ...

LS Group’s US cable affiliate Superior Essex (SPSX) plans to raise $150 million (200 billion won) via a South Korean private equity fund (PEF)...

The listing in the US of NKGen Biotech, the American subsidiary of South Korean developer of natural killer (NK) cell therapy NKMax Co., is coming i...

YG Entertainment Inc., the K-pop label behind global sensation Blackpink, saw its stock hitting the highest point in more than 10 years as a new gro...

South Korea's securities companies on Thursday lowered their target stock prices for retailer Shinsegae International given its sluggish first-quart...

Celltrion Inc. announced on Tuesday it has decided not to pursue the acquisition of the biopharmaceutical unit of U.S. medical device maker Baxter I...

EcoPro BM Co., the top stock on South Korea’s junior bourse Kosdaq, declined on Wednesday as some brokerage houses have downgraded the shares ...

South Korea’s Celltrion Inc. is speeding up global clinical trials of its biosimilar of the multiple sclerosis (MS) treatment Ocrevus (active ...

A South Korean private equity firm leading shareholder activism against SM Entertainment Co. is mired in controversy as it has surfaced that it sold...

Kakao Pay Corp., the mobile payment and digital wallet service unit of South Korean tech giant Kakao Corp., announced on Thursday it has signed an a...

The South Korean financial authorities will investigate whether unfair trading practices are behind leverage trading after massive margin call reque...

Yuanta Securities Korea lowered its target price for S-Oil Corp. to 100,000 won ($75) from 110,000 won on Tuesday, saying the oil refining industry ...

Société Générale S.A. (SocGen) on Monday dumped South Korean shares sending their prices to daily limit lows, which loca...